Genetic Technologies Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Mar 24 | BuyUS$52,787 | Peter Rubinstein | Individual | 617,209 | US$0.086 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 3,046,176 | 2.64% |
VC/PE Firms | 6,230,760 | 5.4% |
Individual Insiders | 9,995,515 | 8.66% |
General Public | 14,228,284 | 12.3% |
Institutions | 81,916,511 | 71% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
81,110,351 | US$5.5m | -1.43% | no data | |||
6,230,760 | US$426.3k | 0% | 0.22% | |||
3,081,321 | US$210.8k | 0% | no data | |||
2,246,860 | US$153.7k | 0% | no data | |||
2,175,000 | US$148.8k | 429% | no data | |||
1,445,514 | US$98.9k | 0% | no data | |||
525,930 | US$36.0k | -0.79% | no data | |||
480,400 | US$32.9k | 114% | no data | |||
420,000 | US$28.7k | -44.6% | no data | |||
401,428 | US$27.5k | -16.4% | no data | |||
380,000 | US$26.0k | 0% | no data | |||
306,080 | US$20.9k | 9.93% | no data | |||
300,000 | US$20.5k | 0% | no data | |||
280,000 | US$19.2k | 0% | no data | |||
270,000 | US$18.5k | -32.5% | no data | |||
250,000 | US$17.1k | -18.3% | no data | |||
242,215 | US$16.6k | 0% | no data | |||
230,000 | US$15.7k | -8% | no data | |||
201,979 | US$13.8k | 0% | no data | |||
201,979 | US$13.8k | 0% | no data | |||
112,200 | US$7.7k | 0% | no data | |||
95,040 | US$6.5k | 6.27% | no data | |||
94,182 | US$6.4k | 0% | no data | |||
63,810 | US$4.4k | 0% | no data | |||
16,700 | US$1.1k | 0% | no data |